Active, Not Recruiting
A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer
NCT04214288
- Conditions
- Advanced ER-Positive HER2-Negative Breast Cancer, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Long Beach, California, United States
- Research Site Fort Myers, Florida, United States
- Research Site St. Petersburg, Florida, United States